Ancef

surgical prophylaxis therapy, Antibiotics, Tuberculosis, Osteoarticular + 16 more

Treatment

13 FDA approvals

5 Active Studies for Ancef

What is Ancef

Cefazolin

The Generic name of this drug

Treatment Summary

Cefazolin is an antibiotic that works by stopping bacteria from forming cell walls. It quickly builds up in the bloodstream and is then passed out of the body in the urine. It is used to treat a wide range of bacterial infections.

Cefazolin

is the brand name

image of different drug pills on a surface

Ancef Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Cefazolin

Cefazolin

1988

96

Approved as Treatment by the FDA

Cefazolin, also known as Cefazolin, is approved by the FDA for 13 uses which include surgical prophylaxis therapy and Respiratory Tract Infections .

surgical prophylaxis therapy

Respiratory Tract Infections

Skin and Subcutaneous Tissue Infection caused by susceptible Bacterial Infections

Bacterial Infections

Antibiotics

Bacterial Infections

Bacterial Infections

Bacterial Infections

Postoperative Infections

Vaginosis, Bacterial

Urinary Tract Infections

Endocarditis, Bacterial

prophylaxis of Postoperative Infections

Effectiveness

How Ancef Affects Patients

Cefazolin (also known as cefazoline or cephazolin) is a type of drug that is injected directly into the body. It has a wide range of effectiveness against bacterial infections, and is rapidly absorbed into the bloodstream and quickly passed out of the body in the urine.

How Ancef works in the body

Cephalosporins work to kill bacteria by stopping them from making cell walls. They do this by attaching to proteins in the bacterial cell wall, preventing the cell from correctly constructing a wall. As the wall fails to form, the bacteria become more vulnerable to enzymes that break apart the cell, leading to the bacteria's death.

When to interrupt dosage

The suggested measure of Ancef hinges on the diagnosed condition, such as prophylaxis of Postoperative Infections, Genital infection caused by vulnerable Bacterial Infections and Communicable Diseases. The sum of dosage is contingent upon the method of administration (e.g. Injection or Powder, for solution - Intravenous) specified in the table below.

Condition

Dosage

Administration

Community Acquired Pneumonia (CAP)

1000.0 mg, , 500.0 mg, 10000.0 mg, 20.0 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 1000.0 mg/mL, 5.0 mg/mg, 50.0 mg/mL, 500.0 mg/mL, 200.0 mg/mL, 100000.0 mg, 300000.0 mg, 20000.0 mg, 225.0 mg/mL, 330.0 mg/mL, 10.0 mg/mL

Intravenous, , Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous; Parenteral, Injection, powder, for solution - Intramuscular; Intravenous; Parenteral, Intravenous; Parenteral, Injection, powder, for solution - Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Injection - Intramuscular, Injection, Intramuscular, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution, Solution - Intravenous, Injection, powder, lyophilized, for solution - Intramuscular, Injection - Intravenous

Communicable Diseases

1000.0 mg, , 500.0 mg, 10000.0 mg, 20.0 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 1000.0 mg/mL, 5.0 mg/mg, 50.0 mg/mL, 500.0 mg/mL, 200.0 mg/mL, 100000.0 mg, 300000.0 mg, 20000.0 mg, 225.0 mg/mL, 330.0 mg/mL, 10.0 mg/mL

Intravenous, , Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous; Parenteral, Injection, powder, for solution - Intramuscular; Intravenous; Parenteral, Intravenous; Parenteral, Injection, powder, for solution - Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Injection - Intramuscular, Injection, Intramuscular, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution, Solution - Intravenous, Injection, powder, lyophilized, for solution - Intramuscular, Injection - Intravenous

Respiratory Tract Infections

1000.0 mg, , 500.0 mg, 10000.0 mg, 20.0 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 1000.0 mg/mL, 5.0 mg/mg, 50.0 mg/mL, 500.0 mg/mL, 200.0 mg/mL, 100000.0 mg, 300000.0 mg, 20000.0 mg, 225.0 mg/mL, 330.0 mg/mL, 10.0 mg/mL

Intravenous, , Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous; Parenteral, Injection, powder, for solution - Intramuscular; Intravenous; Parenteral, Intravenous; Parenteral, Injection, powder, for solution - Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Injection - Intramuscular, Injection, Intramuscular, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution, Solution - Intravenous, Injection, powder, lyophilized, for solution - Intramuscular, Injection - Intravenous

Endocarditis, Bacterial

1000.0 mg, , 500.0 mg, 10000.0 mg, 20.0 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 1000.0 mg/mL, 5.0 mg/mg, 50.0 mg/mL, 500.0 mg/mL, 200.0 mg/mL, 100000.0 mg, 300000.0 mg, 20000.0 mg, 225.0 mg/mL, 330.0 mg/mL, 10.0 mg/mL

Intravenous, , Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous; Parenteral, Injection, powder, for solution - Intramuscular; Intravenous; Parenteral, Intravenous; Parenteral, Injection, powder, for solution - Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Injection - Intramuscular, Injection, Intramuscular, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution, Solution - Intravenous, Injection, powder, lyophilized, for solution - Intramuscular, Injection - Intravenous

Bacterial Infections

1000.0 mg, , 500.0 mg, 10000.0 mg, 20.0 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 1000.0 mg/mL, 5.0 mg/mg, 50.0 mg/mL, 500.0 mg/mL, 200.0 mg/mL, 100000.0 mg, 300000.0 mg, 20000.0 mg, 225.0 mg/mL, 330.0 mg/mL, 10.0 mg/mL

Intravenous, , Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous; Parenteral, Injection, powder, for solution - Intramuscular; Intravenous; Parenteral, Intravenous; Parenteral, Injection, powder, for solution - Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Injection - Intramuscular, Injection, Intramuscular, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution, Solution - Intravenous, Injection, powder, lyophilized, for solution - Intramuscular, Injection - Intravenous

Tuberculosis, Osteoarticular

1000.0 mg, , 500.0 mg, 10000.0 mg, 20.0 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 1000.0 mg/mL, 5.0 mg/mg, 50.0 mg/mL, 500.0 mg/mL, 200.0 mg/mL, 100000.0 mg, 300000.0 mg, 20000.0 mg, 225.0 mg/mL, 330.0 mg/mL, 10.0 mg/mL

Intravenous, , Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous; Parenteral, Injection, powder, for solution - Intramuscular; Intravenous; Parenteral, Intravenous; Parenteral, Injection, powder, for solution - Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Injection - Intramuscular, Injection, Intramuscular, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution, Solution - Intravenous, Injection, powder, lyophilized, for solution - Intramuscular, Injection - Intravenous

catheter device

1000.0 mg, , 500.0 mg, 10000.0 mg, 20.0 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 1000.0 mg/mL, 5.0 mg/mg, 50.0 mg/mL, 500.0 mg/mL, 200.0 mg/mL, 100000.0 mg, 300000.0 mg, 20000.0 mg, 225.0 mg/mL, 330.0 mg/mL, 10.0 mg/mL

Intravenous, , Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous; Parenteral, Injection, powder, for solution - Intramuscular; Intravenous; Parenteral, Intravenous; Parenteral, Injection, powder, for solution - Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Injection - Intramuscular, Injection, Intramuscular, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution, Solution - Intravenous, Injection, powder, lyophilized, for solution - Intramuscular, Injection - Intravenous

Communicable Diseases

1000.0 mg, , 500.0 mg, 10000.0 mg, 20.0 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 1000.0 mg/mL, 5.0 mg/mg, 50.0 mg/mL, 500.0 mg/mL, 200.0 mg/mL, 100000.0 mg, 300000.0 mg, 20000.0 mg, 225.0 mg/mL, 330.0 mg/mL, 10.0 mg/mL

Intravenous, , Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous; Parenteral, Injection, powder, for solution - Intramuscular; Intravenous; Parenteral, Intravenous; Parenteral, Injection, powder, for solution - Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Injection - Intramuscular, Injection, Intramuscular, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution, Solution - Intravenous, Injection, powder, lyophilized, for solution - Intramuscular, Injection - Intravenous

surgical prophylaxis therapy

1000.0 mg, , 500.0 mg, 10000.0 mg, 20.0 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 1000.0 mg/mL, 5.0 mg/mg, 50.0 mg/mL, 500.0 mg/mL, 200.0 mg/mL, 100000.0 mg, 300000.0 mg, 20000.0 mg, 225.0 mg/mL, 330.0 mg/mL, 10.0 mg/mL

Intravenous, , Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous; Parenteral, Injection, powder, for solution - Intramuscular; Intravenous; Parenteral, Intravenous; Parenteral, Injection, powder, for solution - Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Injection - Intramuscular, Injection, Intramuscular, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution, Solution - Intravenous, Injection, powder, lyophilized, for solution - Intramuscular, Injection - Intravenous

Urinary Tract Infections

1000.0 mg, , 500.0 mg, 10000.0 mg, 20.0 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 1000.0 mg/mL, 5.0 mg/mg, 50.0 mg/mL, 500.0 mg/mL, 200.0 mg/mL, 100000.0 mg, 300000.0 mg, 20000.0 mg, 225.0 mg/mL, 330.0 mg/mL, 10.0 mg/mL

Intravenous, , Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous; Parenteral, Injection, powder, for solution - Intramuscular; Intravenous; Parenteral, Intravenous; Parenteral, Injection, powder, for solution - Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Injection - Intramuscular, Injection, Intramuscular, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution, Solution - Intravenous, Injection, powder, lyophilized, for solution - Intramuscular, Injection - Intravenous

Antibiotics

1000.0 mg, , 500.0 mg, 10000.0 mg, 20.0 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 1000.0 mg/mL, 5.0 mg/mg, 50.0 mg/mL, 500.0 mg/mL, 200.0 mg/mL, 100000.0 mg, 300000.0 mg, 20000.0 mg, 225.0 mg/mL, 330.0 mg/mL, 10.0 mg/mL

Intravenous, , Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous; Parenteral, Injection, powder, for solution - Intramuscular; Intravenous; Parenteral, Intravenous; Parenteral, Injection, powder, for solution - Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Injection - Intramuscular, Injection, Intramuscular, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution, Solution - Intravenous, Injection, powder, lyophilized, for solution - Intramuscular, Injection - Intravenous

Vaginosis, Bacterial

1000.0 mg, , 500.0 mg, 10000.0 mg, 20.0 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 1000.0 mg/mL, 5.0 mg/mg, 50.0 mg/mL, 500.0 mg/mL, 200.0 mg/mL, 100000.0 mg, 300000.0 mg, 20000.0 mg, 225.0 mg/mL, 330.0 mg/mL, 10.0 mg/mL

Intravenous, , Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous; Parenteral, Injection, powder, for solution - Intramuscular; Intravenous; Parenteral, Intravenous; Parenteral, Injection, powder, for solution - Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Injection - Intramuscular, Injection, Intramuscular, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution, Solution - Intravenous, Injection, powder, lyophilized, for solution - Intramuscular, Injection - Intravenous

Postoperative Infections

1000.0 mg, , 500.0 mg, 10000.0 mg, 20.0 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 1000.0 mg/mL, 5.0 mg/mg, 50.0 mg/mL, 500.0 mg/mL, 200.0 mg/mL, 100000.0 mg, 300000.0 mg, 20000.0 mg, 225.0 mg/mL, 330.0 mg/mL, 10.0 mg/mL

Intravenous, , Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous; Parenteral, Injection, powder, for solution - Intramuscular; Intravenous; Parenteral, Intravenous; Parenteral, Injection, powder, for solution - Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Injection - Intramuscular, Injection, Intramuscular, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution, Solution - Intravenous, Injection, powder, lyophilized, for solution - Intramuscular, Injection - Intravenous

Skin and Subcutaneous Tissue Infection caused by susceptible Bacterial Infections

1000.0 mg, , 500.0 mg, 10000.0 mg, 20.0 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 1000.0 mg/mL, 5.0 mg/mg, 50.0 mg/mL, 500.0 mg/mL, 200.0 mg/mL, 100000.0 mg, 300000.0 mg, 20000.0 mg, 225.0 mg/mL, 330.0 mg/mL, 10.0 mg/mL

Intravenous, , Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous; Parenteral, Injection, powder, for solution - Intramuscular; Intravenous; Parenteral, Intravenous; Parenteral, Injection, powder, for solution - Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Injection - Intramuscular, Injection, Intramuscular, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution, Solution - Intravenous, Injection, powder, lyophilized, for solution - Intramuscular, Injection - Intravenous

Bacterial Infections

1000.0 mg, , 500.0 mg, 10000.0 mg, 20.0 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 1000.0 mg/mL, 5.0 mg/mg, 50.0 mg/mL, 500.0 mg/mL, 200.0 mg/mL, 100000.0 mg, 300000.0 mg, 20000.0 mg, 225.0 mg/mL, 330.0 mg/mL, 10.0 mg/mL

Intravenous, , Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous; Parenteral, Injection, powder, for solution - Intramuscular; Intravenous; Parenteral, Intravenous; Parenteral, Injection, powder, for solution - Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Injection - Intramuscular, Injection, Intramuscular, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution, Solution - Intravenous, Injection, powder, lyophilized, for solution - Intramuscular, Injection - Intravenous

Bacterial Infections

1000.0 mg, , 500.0 mg, 10000.0 mg, 20.0 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 1000.0 mg/mL, 5.0 mg/mg, 50.0 mg/mL, 500.0 mg/mL, 200.0 mg/mL, 100000.0 mg, 300000.0 mg, 20000.0 mg, 225.0 mg/mL, 330.0 mg/mL, 10.0 mg/mL

Intravenous, , Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous; Parenteral, Injection, powder, for solution - Intramuscular; Intravenous; Parenteral, Intravenous; Parenteral, Injection, powder, for solution - Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Injection - Intramuscular, Injection, Intramuscular, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution, Solution - Intravenous, Injection, powder, lyophilized, for solution - Intramuscular, Injection - Intravenous

Communicable Diseases

1000.0 mg, , 500.0 mg, 10000.0 mg, 20.0 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 1000.0 mg/mL, 5.0 mg/mg, 50.0 mg/mL, 500.0 mg/mL, 200.0 mg/mL, 100000.0 mg, 300000.0 mg, 20000.0 mg, 225.0 mg/mL, 330.0 mg/mL, 10.0 mg/mL

Intravenous, , Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous; Parenteral, Injection, powder, for solution - Intramuscular; Intravenous; Parenteral, Intravenous; Parenteral, Injection, powder, for solution - Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Injection - Intramuscular, Injection, Intramuscular, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution, Solution - Intravenous, Injection, powder, lyophilized, for solution - Intramuscular, Injection - Intravenous

prophylaxis of Postoperative Infections

1000.0 mg, , 500.0 mg, 10000.0 mg, 20.0 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 1000.0 mg/mL, 5.0 mg/mg, 50.0 mg/mL, 500.0 mg/mL, 200.0 mg/mL, 100000.0 mg, 300000.0 mg, 20000.0 mg, 225.0 mg/mL, 330.0 mg/mL, 10.0 mg/mL

Intravenous, , Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous; Parenteral, Injection, powder, for solution - Intramuscular; Intravenous; Parenteral, Intravenous; Parenteral, Injection, powder, for solution - Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Injection - Intramuscular, Injection, Intramuscular, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution, Solution - Intravenous, Injection, powder, lyophilized, for solution - Intramuscular, Injection - Intravenous

Bacterial Infections

1000.0 mg, , 500.0 mg, 10000.0 mg, 20.0 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 1000.0 mg/mL, 5.0 mg/mg, 50.0 mg/mL, 500.0 mg/mL, 200.0 mg/mL, 100000.0 mg, 300000.0 mg, 20000.0 mg, 225.0 mg/mL, 330.0 mg/mL, 10.0 mg/mL

Intravenous, , Injection, powder, for solution, Injection, powder, for solution - Intravenous, Intramuscular; Intravenous; Parenteral, Injection, powder, for solution - Intramuscular; Intravenous; Parenteral, Intravenous; Parenteral, Injection, powder, for solution - Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Injection - Intramuscular, Injection, Intramuscular, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Powder, for solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Solution, Solution - Intravenous, Injection, powder, lyophilized, for solution - Intramuscular, Injection - Intravenous

Warnings

There are 20 known major drug interactions with Ancef.

Common Ancef Drug Interactions

Drug Name

Risk Level

Description

Neomycin

Major

The risk or severity of nephrotoxicity can be increased when Cefazolin is combined with Neomycin.

Tenofovir

Major

Cefazolin may increase the nephrotoxic activities of Tenofovir.

Tenofovir alafenamide

Major

Cefazolin may increase the nephrotoxic activities of Tenofovir alafenamide.

Tenofovir disoproxil

Major

Cefazolin may increase the nephrotoxic activities of Tenofovir disoproxil.

Vibrio cholerae CVD 103-HgR strain live antigen

Major

The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Cefazolin.

image of a doctor in a lab doing drug, clinical research

Ancef Novel Uses: Which Conditions Have a Clinical Trial Featuring Ancef?

There are 3 active trials currently investigating the potential of Ancef to serve as a prophylactic against Postoperative Infections, catheter device and Respiratory Tract Bacterial Infections caused by susceptible microbial agents.

Condition

Clinical Trials

Trial Phases

Postoperative Infections

0 Actively Recruiting

Vaginosis, Bacterial

0 Actively Recruiting

Respiratory Tract Infections

0 Actively Recruiting

Communicable Diseases

0 Actively Recruiting

Endocarditis, Bacterial

0 Actively Recruiting

Bacterial Infections

0 Actively Recruiting

Communicable Diseases

0 Actively Recruiting

Skin and Subcutaneous Tissue Infection caused by susceptible Bacterial Infections

0 Actively Recruiting

prophylaxis of Postoperative Infections

0 Actively Recruiting

Communicable Diseases

0 Actively Recruiting

catheter device

0 Actively Recruiting

Tuberculosis, Osteoarticular

0 Actively Recruiting

Bacterial Infections

0 Actively Recruiting

surgical prophylaxis therapy

0 Actively Recruiting

Community Acquired Pneumonia (CAP)

5 Actively Recruiting

Not Applicable, Phase 1, Phase 3

Bacterial Infections

0 Actively Recruiting

Antibiotics

0 Actively Recruiting

Urinary Tract Infections

0 Actively Recruiting

Bacterial Infections

0 Actively Recruiting

Ancef Reviews: What are patients saying about Ancef?

3.3

Patient Review

6/13/2008

Ancef for Skin Infection

I have a bacterial infection from staph and was given an injection. I'm allergic to penicillin, but this fortunately didn't give me a reaction. I feel that my condition is slowly getting better.

2

Patient Review

12/24/2007

Ancef for Infection of Bone

I was prescribed this treatment by my doctor for a staph infection in my healing broken ankle. So far it's been okay, but I'm wondering why they said no drinking alcohol during the treatment.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about ancef

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is Ancef a penicillin?

"Cefazolin is a cephalosporin antibiotic that is used to treat severe or life-threatening bacterial infections, including those before and after surgery to prevent infection."

Answered by AI

What infections does Ancef treat?

"Cefazolin is an injectable medication used to treat various infections caused by bacteria. These include infections of the skin, bone, joint, genitalia, blood, heart valve, and respiratory and urinary tract. It can also be used to treat biliary tract infections."

Answered by AI

Is Ancef the same as amoxicillin?

"Cephalexin and amoxicillin are two different types of beta-lactam antibiotics. Cephalexin is a cephalosporin antibiotic, and amoxicillin is a penicillin derivative."

Answered by AI

What is the drug Ancef used for?

"Cefazolin is an antibiotic that treats a wide variety of bacterial infections. It may also be used before and during surgery to help prevent infection."

Answered by AI

Clinical Trials for Ancef

Image of Children's Healthcare of Atlanta in Atlanta, United States.

Antibiotic Strategies for Pneumonia in Children

12 - 71
All Sexes
Atlanta, GA

The goal of this clinical trial is to determine if a "watch and wait" antibiotic strategy, called Safety Net Antibiotic Prescribing (SNAP), can safely reduce unnecessary antibiotic use while ensuring that children diagnosed with community-acquired pneumonia get better from their illness. The main aims of this study are: * To compare the effectiveness of SNAP versus immediate antibiotic prescribing in children with mild community-acquired pneumonia (CAP) * To identify which patient groups benefit most from the SNAP strategy * To identify factors that shape implementation of each prescribing strategy. Researchers will compare the SNAP strategy (where parents or guardians are instructed to give antibiotics only if their child is not improving after 72 hours, or sooner if they are worsening) to the immediate antibiotic prescribing strategy (where parents or guardians are instructed to give the antibiotics right after their healthcare visit) to see if one strategy is more effective than the other. Participants will be randomly assigned to either the immediate antibiotic group or the SNAP group at enrollment. Participation lasts 14 days with follow-up surveys at 4, 7, and 14 days after enrollment.

Recruiting
Has No Placebo

Children's Healthcare of Atlanta (+3 Sites)

Todd Florin, MD, MSCE

Have you considered Ancef clinical trials?

We made a collection of clinical trials featuring Ancef, we think they might fit your search criteria.
Go to Trials